Glucosamine
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
glucosamine sulfate potassium chloride, Quantity: 1.5 g (Equivalent: potassium chloride, Qty 369 mg)
Available from:
Sunshine Australia Enterprises Pty Ltd
INN (International Name):
glucosamine sulfate potassium chloride
Pharmaceutical form:
Tablet, uncoated
Composition:
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; crospovidone; magnesium stearate; povidone
Administration route:
Oral
Therapeutic indications:
Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Decrease/reduce/relieve mild joint inflammation/swelling ; Helps enhance/improve/promote joint mobility
Product summary:
Visual Identification: ;
Authorization status:
Licence status A
Authorization date:
2014-01-21
